Patient info Open main menu

Blenrep 100 mg powder for concentrate for solution for infusion – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: Prescription only (POM) ▼ Additional monitoring Details

Medicine strength:
100 mg
Other strengths and forms:
Contains active substance:
ATC code:
Similar medicines:

Summary of Product Characteristics (SmPC) - Blenrep 100 mg powder for concentrate for solution for infusion

Sources: Original (products.mhra.gov.uk)

Facts about Blenrep 100 mg powder for concentrate for solution for infusion

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Belantamab mafodotin
Strength 100 mg
Pharmaceutical form Powder for solution for infusion
How is it taken Intravenous
Pack sizes 1 vial
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01X Other antineoplastic agents
        1. L01XC Monoclonal antibodies, antineoplastic
          1. L01XC39 belantamab mafodotin
Additional monitoring Yes ▼ – new safety information is collected quickly. Report any side effect to the Yellow Card scheme.
Codes GTIN 5054290012149

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.